ANTX Joshua M. Eizen sold AN2 Therapeutics, Inc. shares — SEC Form 4SELLAN2 Therapeutics, Inc.

Joshua M. Eizen, See Remarks at AN2 Therapeutics, Inc. (ANTX), sold 9,663 shares at $1.34 ($13K) on 2025-01-03, disclosed to the SEC on 2025-01-07.

SEC EDGAR Filing

0000950170-25-003152

View on SEC EDGAR

Trade context

Open-market sale of $13k ANTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.

Modest58/100

Nothing distinguishes this filing.

Buy-to-Sell ReversalOpportunistic Sell

Filing Info

Filed2025-01-07

Traded2025-01-03

Accession0000950170-25-003152

Sourcesec_form345

Insider

NameJoshua M. Eizen

TitleSee Remarks

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
ANTX	SELL	2026-07-10	$25K	—	Filing →
ANTX	SELL	2026-01-07	$25K	—

Get alerted the next time ANTX files

Every new ANTX Form 4, within minutes of it hitting EDGAR. 7-day free trial, no credit card required.

Follow ANTX

ANTX Joshua M. Eizen sold AN2 Therapeutics, Inc. shares — SEC Form 4SELLAN2 Therapeutics, Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes